AI-based Digital Pathology Market is Segmented By End-Users (Academic Institutions, Hospitals / Healthcare Institutions, Laboratories, Diagnostic Inst....
Market Size in USD
CAGR8.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.3% |
Market Concentration | High |
Major Players | Aiforia Technologies, Akoya Biosciences, Ibex Medical Analytics, Indica Labs, PathAI |
The AI-based digital pathology market is estimated to be valued at USD 1.1 Bn in 2024 and is expected to reach USD 1.8 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031. The increasing incorporation of AI and digitization of pathology workflows along with the demand for more accurate and faster diagnosis is fueling the growth of this market.
The market is witnessing positive trends with the increasing adoption of digital pathology to enhance workflow efficiency in healthcare facilities. Key players are investing in development of more advanced AI and machine learning-based algorithms and systems to gain major share. Several hospitals and diagnostic centers are also replacing traditional microscopy with digital pathology to meet growing diagnosis needs.